CTSO
CTSO
NASDAQ · Health Care

Cytosorbents Corp

$0.55
-0.02 (-4.31%)
As of May 16, 2:21 AM ET ·
Financial Highlights (FY 2026)
Revenue
36.33M
Net Income
-8,032,266
Gross Margin
71.5%
Profit Margin
-22.1%
Rev Growth
+2.2%
D/E Ratio
2.82
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 71.5% 71.5% 39.9% 39.9%
Operating Margin -41.3% -37.2% 7.7% 9.4%
Profit Margin -22.1% -21.0% 5.8% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 36.33M 35.53M 13.44M 11.40M
Gross Profit 25.97M 25.40M 5.36M 4.54M
Operating Income -15,002,272 -13,207,517 1.03M 1.07M
Net Income -8,032,266 -7,071,348 783.9K 740.1K
Gross Margin 71.5% 71.5% 39.9% 39.9%
Operating Margin -41.3% -37.2% 7.7% 9.4%
Profit Margin -22.1% -21.0% 5.8% 6.5%
Rev Growth +2.2% +2.2% -9.4% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 12.30M 12.30M 11.74M 10.77M
Total Equity 4.35M 4.35M 22.15M 20.33M
D/E Ratio 2.82 2.82 0.53 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -13,795,737 -12,820,062 1.54M 1.35M
Free Cash Flow 1.21M 903.7K